Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 07, 2019

SELL
$81.56 - $100.67 $16,638 - $20,536
-204 Closed
0 $0
Q3 2018

Oct 30, 2018

SELL
$83.5 - $93.23 $132 Million - $147 Million
-1,579,651 Reduced 99.99%
204 $19,000
Q2 2018

Aug 03, 2018

SELL
$79.9 - $89.2 $36.9 Million - $41.2 Million
-462,122 Reduced 22.63%
1,579,855 $135 Million
Q1 2018

Apr 30, 2018

BUY
$71.51 - $84.69 $3.12 Million - $3.7 Million
43,699 Added 2.19%
2,041,977 $171 Million
Q4 2017

Jan 18, 2018

SELL
$63.24 - $72.8 $9 Million - $10.4 Million
-142,311 Reduced 6.65%
1,998,278 $144 Million
Q3 2017

Oct 31, 2017

BUY
$59.73 - $65.4 $128 Million - $140 Million
2,140,589
2,140,589 $136 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Frontier Capital Management CO LLC Portfolio

Follow Frontier Capital Management CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frontier Capital Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frontier Capital Management CO LLC with notifications on news.